7-(methylsulfonyl)quinoline-3-carboxylic acid
- $561.6 - $1950
- Product name: 7-(methylsulfonyl)quinoline-3-carboxylic acid
- CAS: 1956341-19-7
- MF: C11H9NO4S
- MW: 251.26
- EINECS:
- MDL Number:MFCD29059321
- Synonyms:7-(methylsulfonyl)quinoline-3-carboxylic acid;3-Quinolinecarboxylic acid, 7-(methylsulfonyl)-
5 prices
Selected condition:
Brand
- AK Scientific
- Alichem
- Chemenu
- Crysdot
Package
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number8694EF
- Product description7-(Methylsulfonyl)quinoline-3-carboxylicacid
- Packaging1g
- Price$1950
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1956341197
- Product description7-(Methylsulfonyl)quinoline-3-carboxylicacid
- Packaging1g
- Price$1335.51
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1956341197
- Product description7-(Methylsulfonyl)quinoline-3-carboxylicacid
- Packaging250mg
- Price$561.6
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM229355
- Product description7-(Methylsulfonyl)quinoline-3-carboxylicacid 97%
- Packaging1g
- Price$1261
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11172776
- Product description7-(Methylsulfonyl)quinoline-3-carboxylicacid 97%
- Packaging250mg
- Price$835
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8694EF | 7-(Methylsulfonyl)quinoline-3-carboxylicacid | 1g | $1950 | 2021-12-16 | Buy |
Alichem | 1956341197 | 7-(Methylsulfonyl)quinoline-3-carboxylicacid | 1g | $1335.51 | 2021-12-16 | Buy |
Alichem | 1956341197 | 7-(Methylsulfonyl)quinoline-3-carboxylicacid | 250mg | $561.6 | 2021-12-16 | Buy |
Chemenu | CM229355 | 7-(Methylsulfonyl)quinoline-3-carboxylicacid 97% | 1g | $1261 | 2021-12-16 | Buy |
Crysdot | CD11172776 | 7-(Methylsulfonyl)quinoline-3-carboxylicacid 97% | 250mg | $835 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|